CloudMD Software & Services (CVE:DOC) Earns Speculative Buy Rating from Echelon Wealth Partners

CloudMD Software & Services (CVE:DOC)‘s stock had its “speculative buy” rating reissued by investment analysts at Echelon Wealth Partners in a report issued on Wednesday, reports.

Separately, Bloom Burton reiterated a “buy” rating on shares of CloudMD Software & Services in a research report on Wednesday, December 22nd.

Shares of CVE DOC opened at C$0.97 on Wednesday. The company has a debt-to-equity ratio of 15.86, a quick ratio of 1.52 and a current ratio of 1.65. The firm has a market cap of C$224.53 million and a price-to-earnings ratio of -8.90. The business’s 50-day simple moving average is C$1.22 and its 200-day simple moving average is C$1.57. CloudMD Software & Services has a 52 week low of C$0.94 and a 52 week high of C$3.25.

CloudMD Software & Services (CVE:DOC) last issued its quarterly earnings data on Monday, November 29th. The company reported C($0.02) EPS for the quarter. The firm had revenue of C$39.16 million during the quarter. As a group, equities research analysts forecast that CloudMD Software & Services will post -0.05 earnings per share for the current year.

In related news, Director Essam Hamza bought 60,000 shares of the business’s stock in a transaction that occurred on Monday, December 13th. The stock was acquired at an average price of C$1.14 per share, for a total transaction of C$68,400.00. Following the transaction, the director now directly owns 2,819,500 shares of the company’s stock, valued at C$3,214,230.

CloudMD Software & Services Company Profile

CloudMD Software & Services Inc, a healthcare technology company, provides SaaS based health technology solutions to medical clinics in North America. It offers CloudMD telemedicine application, a telemedicine platform that connects patients to licensed physician through videoconferencing technology; operates a network of inter-connected medical clinics; and Re:Function, an integrated network of 8 rehabilitation clinics that offers various rehabilitation services.

Read More: S&P/ASX 200 Index

Receive News & Ratings for CloudMD Software & Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CloudMD Software & Services and related companies with's FREE daily email newsletter.